ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

DCE Proposes AIDS-Cancer Registry For Funding Through $2 Mil. Contract

April 9, 1993

Seven Divisions Proposed, Separating Intramural, Extramural Programs

August 11, 1995

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001